DE60234772D1 - Gruppe-b streptococcus antigene und entsprechende dna-fragmente - Google Patents
Gruppe-b streptococcus antigene und entsprechende dna-fragmenteInfo
- Publication number
- DE60234772D1 DE60234772D1 DE60234772T DE60234772T DE60234772D1 DE 60234772 D1 DE60234772 D1 DE 60234772D1 DE 60234772 T DE60234772 T DE 60234772T DE 60234772 T DE60234772 T DE 60234772T DE 60234772 D1 DE60234772 D1 DE 60234772D1
- Authority
- DE
- Germany
- Prior art keywords
- streptococcus
- group
- antigenic
- dna fragments
- corresponding dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30310101P | 2001-07-06 | 2001-07-06 | |
| PCT/CA2002/001019 WO2003004650A2 (en) | 2001-07-06 | 2002-07-05 | Group b streptococcus antigens and corresponding dna fragments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60234772D1 true DE60234772D1 (de) | 2010-01-28 |
Family
ID=23170538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60234772T Expired - Lifetime DE60234772D1 (de) | 2001-07-06 | 2002-07-05 | Gruppe-b streptococcus antigene und entsprechende dna-fragmente |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7393536B2 (enExample) |
| EP (1) | EP1407023B1 (enExample) |
| JP (2) | JP4374245B2 (enExample) |
| AT (1) | ATE452191T1 (enExample) |
| AU (1) | AU2002317107B2 (enExample) |
| BR (1) | BR0210875A (enExample) |
| CA (1) | CA2453062C (enExample) |
| DE (1) | DE60234772D1 (enExample) |
| ES (1) | ES2337773T3 (enExample) |
| WO (1) | WO2003004650A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7939087B2 (en) * | 2000-10-27 | 2011-05-10 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from Streptococcus groups A & B |
| EP1343895B1 (en) * | 2000-12-21 | 2008-06-18 | ID Biomedical Corporation | Streptococcus pyogenes antigens and corresponding dna fragments |
| JP2005514052A (ja) * | 2001-12-21 | 2005-05-19 | チルドレンズ ホスピタル アンド レジオナル メディカル センター | B群連鎖球菌の新規の細胞表面プロテアーゼの使用 |
| WO2012138470A2 (en) | 2011-04-04 | 2012-10-11 | Intelligent Medical Devices, Inc. | Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group b streptococcus |
| KR101675382B1 (ko) | 2015-04-07 | 2016-11-14 | (주) 씨에스코리아 | 황토보드 제조방법 및 그에 의해 제조되는 황토보드 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0618813B1 (en) | 1992-09-16 | 2002-01-09 | The University Of Tennessee Research Corporation | Antigen of hybrid m protein and carrier for group a streptococcal vaccine |
| DE69836744T2 (de) | 1997-09-12 | 2007-10-04 | University Of Tennessee Research Foundation, Knoxville | Gruppe a streptokokken-impfstoff |
| PL205041B1 (pl) | 1998-12-23 | 2010-03-31 | Id Biomedical Corp | Izolowany polinukleotyd, wektor zawierający izolowany polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca polipeptyd oraz jej zastosowanie w leczeniu lub zapobieganiu zakażeniu osobnika paciorkowcem |
| GB9921125D0 (en) | 1999-09-07 | 1999-11-10 | Microbial Technics Limited | Proteins |
| US7939087B2 (en) * | 2000-10-27 | 2011-05-10 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from Streptococcus groups A & B |
| FR2824074A1 (fr) | 2001-04-26 | 2002-10-31 | Pasteur Institut | Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques |
| US7262024B2 (en) | 2001-12-20 | 2007-08-28 | Id Biomedical Corporation | Streptococcus antigens |
-
2002
- 2002-07-05 WO PCT/CA2002/001019 patent/WO2003004650A2/en not_active Ceased
- 2002-07-05 AT AT02745009T patent/ATE452191T1/de not_active IP Right Cessation
- 2002-07-05 CA CA2453062A patent/CA2453062C/en not_active Expired - Fee Related
- 2002-07-05 JP JP2003510808A patent/JP4374245B2/ja not_active Expired - Fee Related
- 2002-07-05 EP EP02745009A patent/EP1407023B1/en not_active Expired - Lifetime
- 2002-07-05 BR BR0210875-5A patent/BR0210875A/pt active Search and Examination
- 2002-07-05 US US10/482,929 patent/US7393536B2/en not_active Expired - Lifetime
- 2002-07-05 AU AU2002317107A patent/AU2002317107B2/en not_active Ceased
- 2002-07-05 DE DE60234772T patent/DE60234772D1/de not_active Expired - Lifetime
- 2002-07-05 ES ES02745009T patent/ES2337773T3/es not_active Expired - Lifetime
-
2008
- 2008-06-09 US US12/135,911 patent/US7740870B2/en not_active Expired - Lifetime
-
2009
- 2009-06-10 JP JP2009139587A patent/JP5194199B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2453062A1 (en) | 2003-01-16 |
| US7740870B2 (en) | 2010-06-22 |
| JP5194199B2 (ja) | 2013-05-08 |
| BR0210875A (pt) | 2004-06-22 |
| CA2453062C (en) | 2013-04-02 |
| US20040242844A1 (en) | 2004-12-02 |
| WO2003004650A2 (en) | 2003-01-16 |
| JP2009240316A (ja) | 2009-10-22 |
| JP2005501534A (ja) | 2005-01-20 |
| JP4374245B2 (ja) | 2009-12-02 |
| AU2002317107B2 (en) | 2008-06-12 |
| EP1407023B1 (en) | 2009-12-16 |
| US7393536B2 (en) | 2008-07-01 |
| ES2337773T3 (es) | 2010-04-29 |
| ATE452191T1 (de) | 2010-01-15 |
| EP1407023A2 (en) | 2004-04-14 |
| US20090042794A1 (en) | 2009-02-12 |
| WO2003004650A3 (en) | 2003-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200704553T2 (tr) | Streptokok antijenleri. | |
| NO20004161L (no) | Gruppe B streptokoccus antigener | |
| DE60036698D1 (de) | Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen | |
| FR21C1005I2 (fr) | Antigenes de streptococcus pyogenes et fragments d'adn correspondants | |
| ATE463575T1 (de) | Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen | |
| MY129319A (en) | Crystal forms of azithromycin | |
| NO20041917L (no) | Spesifikke midler som binder humant angiopoietin-2 | |
| AU2001235006A1 (en) | Prophylactic and therapeutic monoclonal antibodies | |
| DE60037900D1 (de) | Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen | |
| CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
| WO2001081380A3 (en) | Immunogenic pneumococcal protein and vaccine compositions thereof | |
| DE60034879T8 (de) | Lantibiotikum | |
| ATE412750T1 (de) | Antigen aus streptococcus pyogenes | |
| ATE452191T1 (de) | Gruppe-b streptococcus antigene und entsprechende dna-fragmente | |
| DK1037916T3 (da) | Erythrovirus og dets anvendelser | |
| WO2003068813A3 (en) | Group b streptococcus antigen | |
| ATE369429T1 (de) | Strukturproteine des virus, welches die pankreas- krankheit bei fischen verursacht, und ihre verwendungen | |
| BR0207447A (pt) | Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina | |
| BR0111785A (pt) | Composições e métodos para tratamento de candidìase | |
| WO2002088178A8 (en) | Antigens of group b streptococcus and corresponding dna fragments | |
| WO2002079475A3 (en) | Streptococcus pyogenes antigens and corresponding dna fragments | |
| ATE547527T1 (de) | Gruppe b streptococcus bvh-a2 und bvh-a3 antigene | |
| WO2005017093A3 (en) | Polypeptides of streptococcus pyogenes | |
| DE60031106D1 (de) | Fluordesoxyuridin-resistente streptococcus gordonii stämme | |
| WO2002055019A3 (en) | Methods for ameliorating childhood infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |